Michele Selig Worobiec, JD, CCM
Vice President and Chief Counsel
As vice president and chief counsel for TASC, Michele Selig Worobiec’s executive leadership responsibilities include corporate governance, legal risk management, policy and legislative initiatives, justice system relations, and national and international consulting.
Bringing forth a broad range of legal,
judicial, and policy experience, she is a recognized expert in the development and implementation of justice interventions for people with substance use and mental health conditions, from pre-arrest deflection to court-based interventions to community-based, post-incarceration programs that reduce recidivism.
An international expert on diversion, alternatives to incarceration, and specialized case management, Michele has traveled extensively to offer consultation for states and nations seeking effective strategies for interrupting cycles of substance use and justice system involvement. She has authored curricula and delivered training to cabinet members and national policy leaders, and has also been a featured speaker at numerous conferences, including those hosted by NADCP, American University, and the Indiana State Department of Health.
Michele joined TASC in 2017, bringing more than 20 years' experience in court policy, systems-approach strategies, and evidence-based practices. She began her career as a private attorney in Ohio before serving on the bench for seven years, presiding over criminal and civil cases as well as the drug, mental health, and veterans courts. From there, she advanced to the position of policy counsel for the Supreme Court of Ohio. She was appointed to the National Review Board and the Implementation Advisory Group for the National Association of Drug Court Professionals
(NADCP) Adult Drug Court Best Practice Standards, and is credentialed by the Bureau of Justice Assistance (BJA) as a national consultant. Michele also serves as a board member of the National Alliance for Model State Drug Laws (NAMSDL).
Michele’s wide-ranging justice experience has brought her face-to-face with the nation’s opioid epidemic, and she has led aggressive efforts to diminish the deadly impact of opioids, fentanyl, and other drugs. In 2016, she led the formation of a nine-state regional team to create a first-of-its-kind Regional Judicial Opioid Initiative (RJOI), whose opening summit convened 150 senior-level court, executive branch, elected officials, and private sector delegates. She also provided leadership on Ohio's state initiatives that allocated $20M for specialized dockets and medication-assisted treatment (MAT) for 220 courts, and oversaw the publication of Principles for the Use of Medication Assisted Treatment (MAT) in Drug
Michele earned her BS
in psychology and her JD from The Ohio State University, where she graduated
summa cum laude with honors in the liberal arts, and she was designated as one
of the top 10 graduating seniors by the president of the university. Michele is
admitted to practice law by the U.S. Supreme Court, Supreme Court of Ohio,
Supreme Court of Illinois and US District Court, Northern and Southern
Districts of Ohio. She is also a certified court manager (CCM) by the National
Center for State Courts.